Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| TScan Therapeutics, Inc.(TCRX) | 630,000 | 630,000 | 0 | $869.4K | $913.5K | 42.43% | +$44.1K |
| Werewolf Therapeutics, Inc.(HOWL) | 589,102 | 589,102 | 0 | $572.7K | $642.1K | 29.83% | +$69.4K |
| Barinthus Biotherapeutics PlADS | 642,204 | 642,204 | 0 | $624.7K | $597.3K | 27.74% | -$27.4K |